What You Should Know
Oncology AI innovator Triomics has announced a $22M Series B financing round led by Battery Ventures, pushing its total venture funding past $36 million.The expansion round features strategic backing from Lightspeed, Nexus Venture Partners, Y Combinator, Oncology Ventures, and Precision Health Informatics (a subsidiary of Texas Oncology).Triomics replaces manual medical chart curation by deploying domain-specific AI agents that ingest unstructured longitudinal records,
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
The Intelligence Gap: Why Oncologists Are Buried in Data While Patients Wait for Breakthroughs
In 2026, we live in an era of seamless predictive intelligence. For example: My shopping app often anticipates what I’ll need before I’ve even thought about it. My navigation app quietly diverts me away from traffic jams I haven’t encountered yet.
Yet, the moment a patient or clinician steps into the healthcare ecosystem, this "intelligence" seemingly vanishes. For instance, In a typical ten-year cancer survival journey, there are often only 3–4 critical windows where a change in
Read More
Greatly Health Secures $4M to Scale MSK-Validated Integrative Oncology Platform
What You Should Know
Greatly Health raised a $4 million seed round co-led by Pear VC and Commonweal Ventures to bring integrative oncology to a broader patient population.The company's virtual model was originally developed and validated at Memorial Sloan Kettering Cancer Center (MSK).In clinical trials, the program demonstrated a 16% absolute improvement in overall survival at two years and a 69% reduction in hospitalizations.The platform provides live, expert-led group sessions in exercise,
Read More
Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform
What You Should Know:
- VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure's Halo Intelligence™ platform, an AI-powered clinical decision support system that has already increased tumor sequencing rates by 8x for 30,000 patients.
- Through a partnership with Rales' firm New Bearing, VieCure will implement a world-class business system to modernize community oncology clinics, which treat 80% of U.S. cancer
Read More
The Invisible Gap: Why Oncology EHRs Must Measure Emotional Recovery
In oncology care the clinical community has made remarkable progress in extending survival. Yet we face a persistent invisible gap in care: the emotional and cognitive recovery of patients after treatment ends. Emotional distress in cancer survivors such as anxiety, depression, and pain is not only common but also has measurable impacts on utilization, adherence, and quality of life. The next frontier in digital health is to treat this recovery as a data-driven outcome by embedding it into the
Read More
Microsoft Partners with Qure.ai to Accelerate AI Lung Cancer Detection
What You Should Know:
- Qure.ai, a TIME100 most influential company and global leader in digital healthcare, today announced its collaboration with Microsoft. Qure.ai will onboard its end-to-end lung cancer detection, measurement and management suite of AI-powered solutions onto the Precision Imaging Network.
- This will streamline deployment of Qure.ai solutions to hospitals and health systems across the USA, driving digital healthcare transformation, improved tech integrations and
Read More
SimonMed Launches Ultrasound+ AI Program for Enhanced Breast and Thyroid Cancer Detection
What You Should Know:
- SimonMed Imaging, one of the largest outpatient medical imaging providers and radiology practices in the United States, today announced the launch of Ultrasound+, an AI-enabled ultrasound program.
- The program is powered by the FDA-cleared software, Koios DS, and is designed to assist with breast and thyroid cancer detection.
Embedding AI for Earlier and More Accurate Detection
Ultrasound+ represents a significant step in making advanced imaging
Read More
3 Non-Negotiable Practices for Emotional Recovery in Cancer Care
Clinicians rightly celebrate when treatment ends. Yet many patients leave our clinics still carrying the invisible weight of illness—anxiety, low mood, pain, and a fragile sense of self. The evidence says this is not rare, and it is not trivial. A 2025 umbrella review of cancer survivorship found pooled prevalence rates of 33% for depression and 31% for anxiety, with higher figures during periods of wider societal stress. These symptoms shape adherence, function, and quality of life, long after
Read More
Thyme Care Secures $97M to Scale Value-Based Oncology and AI Infrastructure
What You Should Know:
- Thyme Care, a value-based cancer care enabler secures $97M in Series D funding, bringing its total capital raised to $275M.
The funding round was overwhelmingly backed by strategic investors, including current investors such as CVS Health® Ventures, Foresite Capital, and a16z Bio + Health, with new strategic investors including Morgan Health (JPMorganChase), Humana, Texas Oncology, and Memorial Hermann Health System.
- The company also achieved
Read More
Lunit and Agilent Partner to Develop AI-Powered Companion Diagnostics for Cancer
What You Should Know:
- Lunit, a provider of AI for cancer diagnostics, and Agilent Technologies Inc., a global leader in life sciences, have announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions.
- The strategic partnership will combine Lunit's AI technology with Agilent’s expertise in tissue-based companion diagnostics. The goal is to create advanced solutions that meet the demands of novel and complex biomarker assays in drug
Read More
